Carbimazole Induced Aplastic Anaemia
Abstract
Full Text:
PDFReferences
Young NS.Acquired aplastic anemia. Ann In-tern Med. 2002 Apr 2;136(7):534-46.
Handoko KB, Souverein PC, van Staa TP, Meyboom RH, Leufkens HG, Egberts TC et al. Risk of aplastic anemia in patients using antiepileptic drugs. Epilepsia. 2006 Jul;47(7):1232-6.
Laporte JR, Ibáñez L, Ballarín E, Pérez E, Vi-dal X. Fatal aplastic anaemia associated with ni-fedipine. Lancet. 1998 Aug 22;352(9128):619-20.
Andersohn F, Konzen C, Garbe E. Systematic review: agranulocytosis induced by nonchemo-therapy drugs. Ann Intern Med. 2007 May 1;146(9):657-65.
Cooper DS. The side effects of antithyroid drugs. Endocrinologist 1999; 9: 457-7
Cooper DS. Antithyroid drugs. N Engl J Med. 1984 Nov 22;311(21):1353-62.
Amos RS, Pullar T, Bax DE, Situnayake D, Ca-pell HA, McConkey B. Sulphasalazine for rheuma-toid arthritis: toxicity in 774 patients monitored for one to 11 years. Br Med J (Clin Res Ed). 1986 Aug 16;293(6544):420-3.
Tajiri J, Noguchi S, Murakami T, Murakami N. Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring. Arch Intern Med. 1990 Mar;150(3):621-4.
Kaufman DW, Kelly JP, Levy M, Shapiro S. The Drug Etiology of Agranulocytosis and Aplastic Anemia. New York: Oxford UnivPr; 1991
Young NS, Maciejewski J.The pathophysiolo-gy of acquired aplastic anemia. N Engl J Med. 1997 May 8;336(19):1365-72.
Calado RT, Garcia AB, Gallo DA, Falcão RP. Reduced function of the multidrug resistance P-glycoprotein in CD34+ cells of patients with aplastic anaemia.Br J Haematol. 2002 Jul;118(1):320-6.
Tamai H, Sudo T, Kimura A, Mukuta T, Matsubayashi S, Kuma K, Nagataki S, Sasazuki T. Association between the DRB1*08032 histocom-patibility antigen and methimazole-induced agranulocytosis in Japanese patients with Graves disease. Ann Intern Med. 1996 Mar 1;124(5):490-4.
Fibbe WE, Claas FH, Van der Star-Dijkstra W, Schaafsma MR, Meyboom RH, Falkenburg JH. Agranulocytosis induced by propylthiouracil: evi-dence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoi-etic progenitor cells. Br J Haematol. 1986 Oct;64(2):363-73.
Fincher ME, Fariss BL, Plymate SR, Jones RE, Messier MN.Agranulocytosis and a small dose of methimazole. Ann Intern Med. 1984 Sep;101(3):404-5.
Watanabe N, Narimatsu H, Noh JY, Yamagu-chi T, Kobayashi K, Kami M et al. Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytope-nia involving 50,385 patients with Graves' dis-ease. J ClinEndocrinolMetab. 2012 Jan;97(1):E49-53
Huang CH, Li KL, Wu JH, Wang PN, Juang JH. Antithyroid drug-induced agranulocytosis: report of 13 cases. Chang Gung Med J. 2007 May-Jun;30(3):242-8
Sheng WH, Hung CC, Chen YC, Fang CT, Hsieh SM, Chang SC et al. Antithyroid-drug-induced agranulocytosis complicated by life-threatening infections. QJM. 1999 Aug;92(8):455-61.
Dai WX, Zhang JD, Zhan SW, Xu BZ, Jin H, Yao Y, Xin WC, Bai Y. Retrospective analysis of 18 cas-es of antithyroid drug (ATD)-induced agranulocy-tosis. Endocr J. 2002 Feb;49(1):29-33.
Vanderpump MP, Ahlquist JA, Franklyn JA, Clayton RN. Consensus statement for good prac-tice and audit measures in the management of hypothyroidism and hyperthyroidism. The Re-search Unit of the Royal College of Physicians of London, the Endocrinology and Diabetes Com-mittee of the Royal College of Physicians of Lon-don, and the Society for Endocrinology. BMJ. 1996 Aug 31;313(7056):539-44.
Tajiri J, Noguchi S, Okamura S, Morita M, Tamaru M, Murakami N, Niho Y. Granulocyte col-ony-stimulating factor treatment of antithyroid drug-induced granulocytopenia. Arch Intern Med. 1993 Feb 22;153(4):509-14.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An initiative of The Tamil Nadu Dr M.G.R. Medical University